Dr. Hema Laskhmi Ramkumar, MD

Dr. Ramkumar practices at Fullerton Clinical and Surgical Facility in Fullerton, California.

Dr. Ramkumar's NPI, 1184919524, was assigned on June 14, 2011. Dr. Ramkumar graduated from Feinberg School of Medicine in 2010. Dr. Ramkumar holds California license A121980.

Dr. Ramkumar's primary practice is Fullerton Clinical and Surgical Facility, at 301 W Bastanchury Rd, Fullerton, CA 92835 in Orange County. The practice phone is (949) 706-2887.

Dr. Ramkumar's primary practice is Fullerton Clinical and Surgical Facility in Fullerton, California. Dr. Ramkumar is also affiliated with Providence St. Jude Medical Center. Dmand AI also links Dr. Ramkumar to 1 more hospital, 2 group practices and clinics and 2 medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Ramkumar practices, 4 sites in all. Vendor and product names are available with a free account.

Retina specialist is Dr. Ramkumar's primary specialty in the NPI Registry, under taxonomy code 207WX0107X. Dr. Ramkumar is board certified in ophthalmology by the American Board of Ophthalmology. Dr. Ramkumar is licensed in California.

Dmand AI lists age-related macular degeneration, cataract, conjunctivitis, glaucoma, hypertensive retinopathy, inflammation of iris, laser destruction of retinal or choroid lesions and retinal detachment among the conditions Dr. Ramkumar treats.

CMS data shows 61,018 Medicare services from Dr. Ramkumar across 16 procedure codes in 2024, for 680 Medicare patients. Medicare paid $2,418,457 for them. Every service was in an office.

CMS counts 680 Medicare patients who saw Dr. Ramkumar in 2024. The largest group is 65 to 74, with 252 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 22% are also on Medicaid. Their average risk score is 1.66, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Ramkumar's median patient age at 72, with 56% women.

In 2024, Dr. Ramkumar wrote 586 Medicare Part D claims for 189 patients. 70% of them were for generic drugs. CMS names the drug for 487 of them, across 12 drugs with 11 or more claims each, at $11,874 in total drug cost. In 2023, CMS named 493 claims across 12 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Dr. Ramkumar for performance year 2024, reported as part of a group. Dr. Ramkumar accepts Medicare assignment, so Medicare's approved amount is taken as full payment.

Cataract surgery: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 31 papers to Dr. Ramkumar, published from 2008 to 2024. 2013 was the busiest year, with 3. The most frequent topics are Retina, Tomography, Optical Coherence and Angiogenesis Inhibitors. Dr. Ramkumar has published most often in Retina. Dr. Ramkumar's most frequent co-authors are William R. Freeman, MD, Rohan Verma, MD and Sean David Adrean, MD.

Dmand AI links Dr. Ramkumar to 2 clinical trials. Conditions studied include Macular Degeneration, Retinopathy of Prematurity and Infant, Premature, Diseases. Open Payments lists research payments to Dr. Ramkumar that name 1 trial.

CMS Open Payments shows 145 general payments to Dr. Ramkumar from 22 drug and device companies from 2016 to 2025. Consulting fees make up the largest share, 69% of the total. Genentech, Inc. paid the most, $14,604. It also lists 10 research payments totaling $2,702 from 2019 to 2020, naming 1 clinical trial.

Dr. Ramkumar graduated from Feinberg School of Medicine in 2010.

Dr. Ramkumar is in network with 15 carriers, including Aetna, Elevance and Blue Cross Blue Shield of Michigan. Medicare plans come from the most carriers, 11. Check the plan with the practice before a visit.